A Prospective, Randomized, Double-Blind, Placebo-Controlled Multicenter Trial Comparing Early (7 Day) Corticosteroid Cessation Versus Long-Term, Low-Dose Corticosteroid Therapy
Open accessThe DOI matches its Crossref record; 26 of the 29 references it cites were found in a registry or an index.
Abstract
In Brief Objective: To compare outcomes with early corticosteroid withdrawal (CSWD) and chronic low dose corticosteroid therapy (CCS). Summary Background Data: Final, 5-year results from the first randomized, double-blind, placebo-controlled trial of early CSWD (at 7 days posttransplant) are presented. Methods: Adult recipients of deceased and living donor kidney transplants without delayed graft function were randomized to receive prednisone (5 mg/d after 6 months posttransplant) or CSWD. Blinding was maintained for 5 years. This clinical trial is registered at www.clinicaltrials.gov (NCT00650468). Results: Results in 386 patients CSWD (n = 191), CCS (n = 195) are presented (CSWD; CCS). No differences were observed at 5 years in the proportion of patients experiencing: primary end point (composite of death, graft loss, or moderate/severe acute rejection) (30/191 (15.7%); 28/195 (14.4%)), patient death (11/191(5.8%);13/195 (6.7%)), death-censored graft loss (11/191 (5.8%); 7/195(3.6%)), biopsy confirmed acute rejection (BCAR) (34/191 (17.8%); 21/195 (10.8%), P = 0.058), moderate/severe acute rejection (15/191 (7.9%); 12/195 (6.2%)). Kaplan Meier analyses of the primary end point and its components also showed no differences; but BCAR was higher with CSWD (P = 0.04). Increased BCAR episodes were primarily corticosteroid-sensitive Banff 1A rejections: the incidence of antibody-treated BCAR was similar between groups (11/191 (5.8%); 13/195 (6.7%)). No differences in renal function were observed at 5 years: mean serum creatinine (1.5 ± 0.6; 1.5 ± 0.7 mg/dL), or Cockroft Gault calculated creatinine clearance (58.6 ± 19.7; 59.8 ± 20.5 mL/min). CSWD was associated with improved serum triglycerides (evaluated by mean and median change from baseline) at all time points (except at 5 years measured by mean change). Weight change also demonstrated changes favoring CSWD (median change from baseline at 5 years: 5.1 vs. 7.7 kg, P = 0.05). New onset diabetes after transplant (NODAT) was similar with respect to proportions who required treatment (23/107 (21.5%)); 18/86 (20.9%); however, fewer CSWD patients required insulin for NODAT at 5 years (4/107 (3.7%)); 10/86 (11.6%), P = 0.049). Changes in HgA1c values (from baseline) were lower in CSWD patients at all time points except 4 years. Conclusions: Early CSWD, compared with CCS, is associated with an increase in BCAR primarily because of mild, Banff 1A, steroid-sensitive rejection, yet provides similar long-term renal allograft survival and function. CSWD provides improvements in cardiovascular risk factors (triglycerides, NODAT requiring insulin, weight gain). Tacrolimus/MMF/antibody induction therapy allows early CSWD with results comparable to long-term low dose (5 mg/d) prednisone therapy. Final results from the first prospective, randomized, placebo-controlled, double-blind trial of early corticosteroid withdrawal in kidney transplantation are reported. This trial, which was blinded for 5 years, demonstrates that early corticosteroid withdrawal (under induction therapy with tacrolimus/mycophenolate mofetil therapy), as compared to chronic corticosteroid therapy, provides similar patient survival, and renal allograft survival and function. Early corticosteroid withdrawal was associated with increased acute rejection risk, but also provided improvements in several corticosteroid-related morbidities including post-transplant diabetes, weight gain, and triglycerides.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Other more unique risk factors in this population include genetic polymorphisms, polycystic kidney disease, hepatitis C, and cytomegalovirus status.1579–1581”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1581]
Citations
Cites
Prediction of Creatinine Clearance from Serum Creatinine
Cockcroft, D. W., & Gault, H. (1976) · Nephron · doi:10.1159/000180580 · Cited by 15,309
Moher, D., Schulz, K. F., & Altman, D. G. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04337-3 · Cited by 5,373
The Banff 97 working classification of renal allograft pathology
Racusen, L. C., Solez, K., Colvin, R. B., Bonsib, S. M., Castro, M. C., Cavallo, T., Croker, B. P., Demetris, A. J., Drachenberg, C. B., Fogo, A. B., et al. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00299.x · Cited by 3,033
Immunosuppression: Evolution in Practice and Trends, 1994–2004
Meier-Kriesche, H.-U., Li, S., Gruessner, R. W. G., Fung, J. J., Bustami, R. T., Barr, M. L., & Leichtman, A. B. (2006) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2006.01270.x · Cited by 559
&NA; (1999) · Transplantation · doi:10.1097/00007890-199912270-00009 · Cited by 277
Rostaing, L., Cantarovich, D., Mourad, G., Budde, K., Rigotti, P., Mariat, C., Margreiter, R., Capdevilla, L., Lang, P., Vialtel, P., et al. (2005) · Transplantation · doi:10.1097/01.tp.0000154915.20524.0a · Cited by 249
Effects of Low-Dose Prednisone on Bone Metabolism
Ton, F. N., Gunawardene, S. C., Lee, H., & Neer, R. M. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.041125 · Cited by 223
Vanrenterghem, Y., Lebranchu, Y., Hen??, R., Oppenheimer, F., & Ekberg, H. (2000) · Transplantation · doi:10.1097/00007890-200011150-00015 · Cited by 213
Sinclair, N. (1992) · Europe PMC (PubMed Central) · Cited by 203
Ratcliffe, P., Dudley, C., Higgins, R., Firth, J., Smith, B., & Morris, P. (1996) · The Lancet · doi:10.1016/s0140-6736(96)02510-x · Cited by 178
Research works printed but not linked: 2
- Sinclair, 1992, Low-dose steroid therapy in cyclosporine-treated renal transplant recipients with well-functioning grafts., Can Med Assoc J, 147, 645
- Woodle, 2005, A randomized, prospective, multicenter study of thymoglobulin in renal transplantation for induction and minimization of steroids (TRIMS)., Am J Transplant, 5, 571
Cited by
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Hypertension · doi:10.1161/hyp.0000000000000065 · Cited by 7,391
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.11.006 · Cited by 6,616
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
Eckardt, K.-U., Kasiske, B. L., & Zeier, M. G. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02834.x · Cited by 1,499
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000596 · Cited by 1,127
Long-Term Survival after Kidney Transplantation
Hariharan, S., Israni, A. K., & Danovitch, G. (2021) · New England Journal of Medicine · doi:10.1056/nejmra2014530 · Cited by 664
Sharif, A., Hecking, M., de Vries, A. P. J., Porrini, E., Hornum, M., Rasoul-Rockenschaub, S., Berlakovich, G., Krebs, M., Kautzky-Willer, A., Schernthaner, G., et al. (2014) · American Journal of Transplantation · doi:10.1111/ajt.12850 · Cited by 532
“However, a beneficial effect of corticosteroid sparing strategies has not been demonstrated (40).”
BackgroundBlonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Alemtuzumab Induction in Renal Transplantation
Hanaway, M. J., Woodle, E. S., Mulgaonkar, S., Peddi, V. R., Kaufman, D. B., First, M. R., Croy, R., & Holman, J. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009546 · Cited by 383
Self-citationPost-transplant diabetes mellitus in patients with solid organ transplants
Jenssen, T., & Hartmann, A. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0137-7 · Cited by 278
Prevention of cardiovascular disease in adult recipients of kidney transplants
Jardine, A. G., Gaston, R. S., Fellstrom, B. C., & Holdaas, H. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61334-2 · Cited by 281
Knight, S. R., & Morris, P. J. (2010) · Transplantation · doi:10.1097/tp.0b013e3181c518cc · Cited by 265
Steroid avoidance or withdrawal for kidney transplant recipients
Haller, M. C., Royuela, A., Nagler, E. V., Pascual, J., & Webster, A. C. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005632.pub3 · Cited by 258
Cardiovascular morbidity and mortality after kidney transplantation
Stoumpos, S., Jardine, A. G., & Mark, P. B. (2015) · Transplant International · doi:10.1111/tri.12413 · Cited by 226
Ferguson, R., Grinyó, J., Vincenti, F., Kaufman, D. B., Woodle, E. S., Marder, B. A., Citterio, F., Marks, W. H., Agarwal, M., Wu, D., et al. (2011) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2010.03338.x · Cited by 209
Self-citationBaker, R. J., Mark, P. B., Patel, R. K., Stevens, K. K., & Palmer, N. (2017) · BMC Nephrology · doi:10.1186/s12882-017-0553-2 · Cited by 211
“Early withdrawal and avoidance studies show increased acute rejection rates but without an effect on graft survival [136, 137, 229].”
BackgroundLong-Term Immunosuppression Management: Opportunities and Uncertainties
Wojciechowski, D., & Wiseman, A. (2021) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.15040920 · Cited by 170
Grenda, R., Watson, A., Trompeter, R., Tönshoff, B., Jaray, J., Fitzpatrick, M., Murer, L., Vondrak, K., Maxwell, H., Van Damme-Lombaerts, R., et al. (2010) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2010.03047.x · Cited by 186
Thomusch, O., Wiesener, M., Opgenoorth, M., Pascher, A., Woitas, R. P., Witzke, O., Jaenigen, B., Rentsch, M., Wolters, H., Rath, T., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)32187-0 · Cited by 165
Immunosuppression for kidney transplantation: Where are we now and where are we going?
Lim, M. A., Kohli, J., & Bloom, R. D. (2016) · Transplantation Reviews · doi:10.1016/j.trre.2016.10.006 · Cited by 158
Sarwal, M., Ettenger, R. B., Dharnidharka, V. R., Benfield, M. R., Mathias, R., Portale, A. A., McDonald, R. A., Harmon, W., Kershaw, D. S., Vehaskari, V. M., et al. (2012) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2012.04145.x · Cited by 157
Luan, F. L., Steffick, D., & OJO, A. O. (2011) · Transplantation · doi:10.1097/tp.0b013e318203c25f · Cited by 156
New-Onset Diabetes After Kidney Transplantation—Changes and Challenges
Yates, C. J., Fourlanos, S., Hjelmesæth, J., Colman, P. G., & Cohney, S. J. (2012) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2011.03855.x · Cited by 147
Reduced Fracture Risk With Early Corticosteroid Withdrawal After Kidney Transplant
Nikkel, L. E., Mohan, S., Zhang, A., McMahon, D. J., Boutroy, S., Dube, G. K., Tanrıöver, B., Cohen, D., Ratner, L. E., Hollenbeak, C., et al. (2011) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2011.03872.x · Cited by 146
Solid-Organ Transplantation in Older Adults: Current Status and Future Research
Abecassis, M., Bridges, N. D., Clancy, C. J., Dew, M. A., Eldadah, B., Englesbe, M. J., Flessner, M. F., Frank, J. C., Friedewald, J., Gill, J., et al. (2012) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2012.04245.x · Cited by 140
BIA, M. J., Adey, D., Bloom, R. D., Chan, L. K., Kulkarni, S., & Tomlanovich, S. (2010) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2010.04.010 · Cited by 141
The need for minimization strategies: current problems of immunosuppression
Bamoulid, J., Staeck, O., Halleck, F., Khadzhynov, D., Brakemeier, S., Dürr, M., & Budde, K. (2015) · Transplant International · doi:10.1111/tri.12553 · Cited by 153
Bergmann, T. K., Barraclough, K. A., Lee, K., & Staatz, C. E. (2012) · Clinical Pharmacokinetics · doi:10.1007/s40262-012-0007-8 · Cited by 146
Nelson, J., Alvey, N., Bowman, L., Schulte, J., Segovia, M. C., McDermott, J., Te, H. S., Kapila, N., Levine, D. J., Gottlieb, R. L., et al. (2022) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2716 · Cited by 130
Steroids and Recurrent IgA Nephropathy After Kidney Transplantation
Clayton, P. A., McDonald, S. P., & Chadban, S. J. (2011) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2011.03667.x · Cited by 129
Novel views on new-onset diabetes after transplantation: development, prevention and treatment
Hecking, M., Werzowa, J., Haidinger, M., Horl, W. H., Pascual, J., Budde, K., Luan, F. L., Ojo, A., de Vries, A. P. J., Porrini, E., et al. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfs583 · Cited by 120
Heilman, R. L., Devarapalli, Y., Chakkera, H. A., Mekeel, K., Moss, A. A., Mulligan, D. C., Mazur, M. J., Hamawi, K., Williams, J. W., & Reddy, K. S. (2010) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02966.x · Cited by 120
A Rationale for Age-Adapted Immunosuppression in Organ Transplantation
Krenzien, F., Elkhal, A., Quante, M., Biefer, H. R. C., Hirofumi, U., Gabardi, S., & Tullius, S. G. (2015) · Transplantation · doi:10.1097/tp.0000000000000842 · Cited by 124
New-onset diabetes mellitus after kidney transplantation: Current status and future directions
Palepu, S. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i3.445 · Cited by 119
Management of post‐transplant diabetes: immunosuppression, early prevention, and novel antidiabetics
Hecking, M., Sharif, A., Eller, K., & Jenssen, T. G. (2020) · Transplant International · doi:10.1111/tri.13783 · Cited by 125
Pascual, J., Royuela, A., Galeano, C., Crespo, M., & Zamora, J. (2012) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr374 · Cited by 112
Selection of induction therapy in kidney transplantation
Hardinger, K. L., Brennan, D. C., & Klein, C. L. (2012) · Transplant International · doi:10.1111/tri.12043 · Cited by 104
Iyer, S. P., Nikkel, L. E., Nishiyama, K. K., Dworakowski, E., Cremers, S., Zhang, C. A., McMahon, D. J., Boutroy, S., Liu, X. S., Ratner, L. E., et al. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013080851 · Cited by 104
Hellemans, R., Bosmans, J., & Abramowicz, D. (2016) · American Journal of Transplantation · doi:10.1111/ajt.13884 · Cited by 99
Höcker, B., Weber, L. T., Feneberg, R., Drube, J., John, U., Fehrenbach, H., Pohl, M., Zimmering, M., Fründ, S., Klaus, G., et al. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp506 · Cited by 103
Thirty Years of Tacrolimus in Clinical Practice
Ong, S., & Gaston, R. S. (2020) · Transplantation · doi:10.1097/tp.0000000000003350 · Cited by 96
Pirsch, J. D., Henning, A. K., First, M. R., Fitzsimmons, W., Gaber, A. O., Reisfield, R., Shihab, F., & Woodle, E. S. (2015) · American Journal of Transplantation · doi:10.1111/ajt.13247 · Cited by 95
Self-citationEmerging treatments for post-transplantation diabetes mellitus
Jenssen, T., & Hartmann, A. (2015) · Nature Reviews Nephrology · doi:10.1038/nrneph.2015.59 · Cited by 90
Gaber, A. O., Monaco, A. P., Russell, J. A., Lebranchu, Y., & Mohty, M. (2010) · Drugs · doi:10.2165/11315940-000000000-00000 · Cited by 88
Self-citationTen-Year Outcome after Rapid Discontinuation of Prednisone in Adult Primary Kidney Transplantation
Rizzari, M. D., Suszynski, T. M., Gillingham, K. J., Dunn, T. B., Ibrahim, H. N., Payne, W. D., Chinnakotla, S., Finger, E. B., Sutherland, D. E. R., Kandaswamy, R., et al. (2012) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.08630811 · Cited by 86
Metabolic consequences of modern immunosuppressive agents in solid organ transplantation
Bamgbola, O. (2016) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018816641580 · Cited by 85
Novel Strategies in Immunosuppression: Issues in Perspective
Webber, A. B., Hirose, R., & Vincenti, F. G. (2011) · Transplantation · doi:10.1097/tp.0b013e3182145306 · Cited by 90
Dyslipidemia and its therapeutic challenges in renal transplantation
Riella, L. V., Gabardi, S., & Chandraker, A. (2012) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2012.04084.x · Cited by 82
“This has been confirmed in early corticosteroid withdrawal analyses that show beneficial effects in reducing dyslipidemia (11).”
BackgroundMedjeral‐Thomas, N., Lawrence, C., Condon, M. B., Sood, B. R., Warwicker, P., Brown, H., Pattison, J. M., Bhandari, S., Barratt, J., Turner, N., et al. (2020) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.06180519 · Cited by 83
Bamoulid, J., Staeck, O., Crépin, T., Halleck, F., Saas, P., Brakemeier, S., Ducloux, D., & Budde, K. (2016) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfw368 · Cited by 83
Risk factors for new-onset diabetes after kidney transplantation
Sharif, A., & Baboolal, K. (2010) · Nature Reviews Nephrology · doi:10.1038/nrneph.2010.66 · Cited by 84
Association Between Steroid Dosage and Death With a Functioning Graft After Kidney Transplantation
Opelz, G., & Döhler, B. (2013) · American Journal of Transplantation · doi:10.1111/ajt.12313 · Cited by 75
Recent Developments in Kidney Transplantation-A Critical Assessment
Womer, K. L., & Kaplan, B. E. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02639.x · Cited by 75
Tanrıöver, B., Zhang, S., MacConmara, M. P., Gao, A., Sandıkçı, B., Ayvaci, M., Mete, M., Tsapepas, D. S., Rajora, N., Mohan, P., et al. (2015) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.08710814 · Cited by 75
Fong, J. N., & Moore, L. W. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00302 · Cited by 83
Obesity in kidney transplantation
Chan, W., Bosch, J. A., Jones, D., McTernan, P. G., Phillips, A. C., & Borrows, R. (2014) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2013.09.002 · Cited by 73
Woodle, E. S., Peddi, V. R., Tomlanovich, S. J., Mulgaonkar, S. P., Kuo, P. C., & for the TRIMS Study Investigators (2009) · Clinical Transplantation · doi:10.1111/j.1399-0012.2009.01127.x · Cited by 73
Self-citationWoodle, E. S., Kaufman, D. B., Shields, A. R., Leone, J. P., Matas, A. J., Wiseman, A. C., West‐Thielke, P. M., Sa, T., King, E. C., & Alloway, R. R. (2019) · American Journal of Transplantation · doi:10.1111/ajt.15688 · Cited by 72
Self-citationMohty, M., Bacigalupo, A., Saliba, F., Zuckermann, A., Morelon, E., & Lebranchu, Y. (2014) · Drugs · doi:10.1007/s40265-014-0277-6 · Cited by 71
Current trends in immunosuppressive therapies for renal transplant recipients
Lee, R.-A., & Gabardi, S. (2012) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp110624 · Cited by 70
Tanrıöver, B., Jaikaransingh, V., MacConmara, M. P., Parekh, J. R., Levea, S.-L. L., Ariyamuthu, V. K., Zhang, S., Gao, A., Ayvaci, M., Sandıkçı, B., et al. (2016) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.13171215 · Cited by 70
Knoll, G. A., Blydt‐Hansen, T. D., Campbell, P. M., Cantarovich, M., Cole, E., Fairhead, T., Gill, J. S., Gourishankar, S., Hébert, D., Hodsman, A. B., et al. (2010) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2010.05.004 · Cited by 69
The role of T hymoglobulin induction in kidney transplantation: an update
Mourad, G., Morélon, E., Noël, C., Glotz, D., & Lebranchu, Y. (2012) · Clinical Transplantation · doi:10.1111/ctr.12021 · Cited by 68
Steroids in kidney transplant patients
Steiner, R. W., & Awdishu, L. (2011) · Seminars in Immunopathology · doi:10.1007/s00281-011-0259-7 · Cited by 68
Metabolic Syndrome in Kidney Transplantation: Management of Risk Factors
Hricik, D. E. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01200211 · Cited by 67
Baker, R. J., Jardine, A. G., & Andrews, P. (2011) · Nephron Clinical Practice · doi:10.1159/000328074 · Cited by 67
Mesenchymal stromal cells for tolerance induction in organ transplantation
Casiraghi, F., Perico, N., & Remuzzi, G. (2017) · Human Immunology · doi:10.1016/j.humimm.2017.12.008 · Cited by 68
Biomarkers as a Tool for Management of Immunosuppression in Transplant Patients
Wieland, E., Olbricht, C. J., Süsal, C., Gurragchaa, P., Böhler, T., Israeli, M., Sommerer, C., Budde, K., Hartmann, B., Shipkova, M., et al. (2010) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0b013e3181efb3d2 · Cited by 64
New-Onset Diabetes After Kidney Transplantation: Prevalence, Risk Factors, and Management
Sarno, G., Muscogiuri, G., & Rosa, P. D. (2012) · Transplantation · doi:10.1097/tp.0b013e31824db97d · Cited by 64
Hypertension in the kidney transplant recipient
Wadei, H. M., & Textor, S. C. (2010) · Transplantation Reviews · doi:10.1016/j.trre.2010.02.001 · Cited by 66
Metabolic Disorders with Kidney Transplant
Cohen, E., Korah, M. M., Callender, G. G., Aguiar, R. B. D., & Haakinson, D. J. (2020) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.09310819 · Cited by 65
New‐onset diabetes after renal transplantation
Tufton, N., Ahmad, S., Rolfe, C., Rajkariar, R., Byrne, C., & Chowdhury, T. A. (2014) · Diabetic Medicine · doi:10.1111/dme.12534 · Cited by 56
Krämer, B. K., Klinger, M., Vitko, S., Głyda, M., Midtvedt, K., Stefoni, S., Citterio, F., Pietruck, F., Squifflet, J., Segoloni, G., et al. (2012) · Transplantation · doi:10.1097/tp.0b013e31825c1d6c · Cited by 61
Diaz-Siso, J. R., Fischer, S., Sisk, G. C., Bueno, E. M., Kueckelhaus, M., Talbot, S. G., Carty, M. J., Treister, N. S., Marty, F. M., Milford, E. L., et al. (2015) · American Journal of Transplantation · doi:10.1111/ajt.13103 · Cited by 56
Lebranchu, Y., Snanoudj, R., Toupance, O., Weestel, P.-F., de Ligny, B. H., Büchler, M., Rérolle, J. P., Thierry, A., Moulin, B., Subra, J., et al. (2012) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2012.04036.x · Cited by 55
Diabetes Mellitus in the Transplanted Kidney
Peev, V., Reiser, J., & Alachkar, N. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00141 · Cited by 55
Immunosuppression in Solid-Organ Transplantation: Essentials and Practical Tips
Jasiak, N., & Park, J. M. (2016) · Critical Care Nursing Quarterly · doi:10.1097/cnq.0000000000000117 · Cited by 43
Immunosuppression and Post-transplant Hyperglycemia
Montero, N., & Pascual, J. (2015) · Current Diabetes Reviews · doi:10.2174/1573399811666150331160846 · Cited by 54
Mourad, G., Głyda, M., Albano, L., Viklický, O., Merville, P., Tydén, G., Mourad, M., Lõhmus, A., Witzke, O., Christiaans, M. H. L., et al. (2016) · Transplantation · doi:10.1097/tp.0000000000001453 · Cited by 53
Prókai, Á., Fekete, A., Pásti, K., Rusai, K., Bánki, N. F., Reusz, G., & Szabo, A. J. (2011) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2011.00782.x · Cited by 52
Glucocorticoids use in kidney transplant setting
de Lucena, D. D., & Rangel, É. B. (2018) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2018.1530214 · Cited by 58
Woodle, E. S., Gill, J. S., Clark, S. R., Stewart, D. E., Alloway, R. R., & First, R. M. (2021) · JAMA Surgery · doi:10.1001/jamasurg.2020.6929 · Cited by 50
Self-citationCurrent Landscape for T-Cell Targeting in Autoimmunity and Transplantation
Getts, D. R., Shankar, S., Chastain, E. M. L., Martin, A. J., Getts, M. T., Wood, K. J., & Miller, S. D. (2011) · Immunotherapy · doi:10.2217/imt.11.61 · Cited by 53
Induction Therapy in Renal Transplant Recipients: How Convincing is the Current Evidence?
Wagner, S. J., & Brennan, D. C. (2012) · Drugs · doi:10.2165/11631300-000000000-00000 · Cited by 50
Dong, M., Parsaik, A. K., Eberhardt, N. L., Basu, A., Cosío, B. G., & Kudva, Y. C. (2012) · Diabetic Medicine · doi:10.1111/j.1464-5491.2012.03617.x · Cited by 49
New-onset diabetes after transplantation: Risk factors and clinical impact
Räkel, A., & Karelis, A. D. (2011) · Diabetes & Metabolism · doi:10.1016/j.diabet.2010.09.003 · Cited by 52
Personalized immunosuppression after kidney transplantation
Cheung, C. Y., & Tang, S. C. W. (2022) · Nephrology · doi:10.1111/nep.14035 · Cited by 52
Immunosuppression in Simultaneous Pancreas-Kidney Transplantation: Progress to Date
Heilman, R. L., Mazur, M. J., & Reddy, K. S. (2010) · Drugs · doi:10.2165/11535430-000000000-00000 · Cited by 47
Naesens, M., Salvatierra, O., Benfield, M. R., Ettenger, R. B., Dharnidharka, V. R., Harmon, W., Mathias, R., & Sarwal, M. (2012) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2012.04144.x · Cited by 47
Recurrent Glomerulonephritis Under Rapid Discontinuation of Steroids
Kukla, A., Chen, E., Spong, R., Weber, M. E., Shahawy, Y. E., Gillingham, K. J., Matas, A. J., & Ibrahim, H. N. (2011) · Transplantation · doi:10.1097/tp.0b013e31821bf157 · Cited by 47
Klem, P. M., Cooper, J. E., Weiss, A. S., Gralla, J., Owen, P. S., Chan, L. K., & Wiseman, A. C. (2009) · Transplantation · doi:10.1097/tp.0b013e3181b6f38c · Cited by 47
Barraclough, K. A., Staatz, C. E., Johnson, D. W., Lee, K., McWhinney, B. C., Ungerer, J. P. J., Hawley, C. M., Campbell, S. B., Leary, D. R., & Isbel, N. M. (2012) · Transplant International · doi:10.1111/j.1432-2277.2012.01553.x · Cited by 46
Lessons Learned: Experiences of Gaining Weight by Kidney Transplant Recipients
Stanfill, A., Bloodworth, R., & Cashion, A. (2012) · Progress in Transplantation · doi:10.7182/pit2012986 · Cited by 44
Zuckermann, A. O., Schulz, U., Deuse, T., Ruhpawar, A., Schmitto, J. D., Beiras-Fernández, A., Hirt, S. W., Schweiger, M., Fernandes, L. K., & Barten, M. J. (2014) · Transplant International · doi:10.1111/tri.12480 · Cited by 46
Induction Antibody Therapy in Kidney Transplantation
Padiyar, A., Augustine, J. J., & Hricik, D. E. (2009) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2009.06.020 · Cited by 45
Grafals, M., Smith, B., Murakami, N., Trabucco, A., Hamill, K., Marangos, E., Gilligan, H. M., Pomfret, E. A., Pomposelli, J. J., Simpson, M. A., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104408 · Cited by 44
Luan, F. L., Steffick, D., & OJO, A. O. (2009) · Kidney International · doi:10.1038/ki.2009.248 · Cited by 44
Favoring the Risk–Benefit Balance for Upper Extremity Transplantation—The Pittsburgh Protocol
Gorantla, V. S., Brandacher, G., Schneeberger, S., Zheng, X. X., Donnenberg, A. D., Losee, J. E., & Lee, W. P. A. (2011) · Hand Clinics · doi:10.1016/j.hcl.2011.08.008 · Cited by 43
Langsford, D., & Dwyer, K. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i10.1132 · Cited by 44
Cantarovich, D., Rostaing, L. P. E., Kamar, N., Ducloux, D., Saint-Hillier, Y., Mourad, G., Garrigue, V., Wolf, P., Ellero, B., Cassuto, É., et al. (2014) · American Journal of Transplantation · doi:10.1111/ajt.12866 · Cited by 41
Randomized Trial of Three Induction Antibodies in Kidney Transplantation: Long-Term Results
Ciancio, G., Gaynor, J. J., Guerra, G., Sageshima, J., Chen, L., Mattiazzi, A. D., Roth, D., Kupin, W. L., Tueros, L., Flores, S., et al. (2014) · Transplantation · doi:10.1097/01.tp.0000441089.39840.66 · Cited by 40
Metadata
- Authors
- Woodle, E. S., First, M. R., Pirsch, J., Shihab, F., Gaber, A. O., & Van Veldhuisen, P.
- Affiliations
- University of Cincinnati (US)
- Astellas Pharma (United States) (US)
- University of Wisconsin–Madison (US)
- University of Utah (US)
- Houston Methodist (US)
- Corresponding author
- Woodle, E Steve
- Venue
- Annals of Surgery
- Published
- 2008-10
- Volume
- 248
- Issue
- 4
- Pages
- 564-577
- ISSN
- 0003-4932 (ISSN-L)
- OpenAlex
- W2026860062
- Cited by
- 474
- References
- 29
- Citations by year
- 2026: 6 · 2025: 20 · 2024: 8 · 2023: 13 · 2022: 14 · 2021: 25 · 2020: 24 · 2019: 26 · 2018: 22 · 2017: 25 · 2016: 32 · 2015: 26 · 2014: 45 · 2013: 29 · 2012: 43
- FWCI
- 29.87
- Type
- journal article
- Language
- en
- Open access
- green
- works.bepress.com
- Licence
- cc-by
- Locations
- Annals of Surgery (publishedVersion)
- PubMed (publishedVersion)
- Journal of Bioresource Management (submittedVersion)
- Journal of Bioresource Management (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Transplantation › Renal Transplantation Outcomes and Treatments
- Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Organ Donation and Transplantation
- Keywords
- corticosteroid withdrawal, kidney transplantation, prednisone, acute rejection, graft loss, patient death, antibody-mediated rejection, renal function, immunosuppression, delayed graft function, deceased donor, living donor, long-term outcomes, corticosteroid-sparing immunosuppression
- MeSH terms
- Adolescent, Adult, Aged, Biopsy, Dose-Response Relationship, Drug, Double-Blind Method, Drug Administration Schedule, Female, Follow-Up Studies, Glucocorticoids, Graft Rejection, Humans, Kidney Failure, Chronic, Male, Middle Aged, Prednisone, Prospective Studies, Time Factors, Kidney Transplantation, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.